Stay updated on Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page.

Latest updates to the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page
- Check6 days agoChange DetectedThe Locations section was updated with new sites across multiple US states and international locations (including Deutschland, Hesse, Greater London, Greater Manchester, HAMPSHIRE). Several previously listed sites were removed, aligning with revision v3.3.3 (previously v3.3.2).SummaryDifference2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedPage footer revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoval of the government funding/status notice is not expected to affect the study details presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check56 days agoChange DetectedAdded a new study site entry for Southampton, Hampshire, United Kingdom (SO16 6DU) on 2025-10-28, after the Hampshire location was removed on 2025-03-06.SummaryDifference0.7%

- Check85 days agoChange DetectedSignificant update to operating status and version bumped to v3.2.0; removes reference to v3.1.0.SummaryDifference4%

- Check92 days agoChange DetectedAdded version tag v3.1.0 and removed several drug-safety topic sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); core content shifts toward new revision labeling with potential loss of previously listed topics.SummaryDifference0.4%

Stay in the know with updates to Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page.